Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2852)	2/7/2001 10:28:37 PM
From: Biomaven	Read Replies (1) of 52153

This is an interesting study of time from IND to NDA for pharmas in the 80's and 90's: diahome.org The fastest companies were Zeneca (now AZN), Glaxo, Merck, Pfizer and (surprise) Abbott. The differences were pretty dramatic - the average AZN time of 3.7 years was a full two years faster than the 5.7 year average. The bottom quartile took over 12 years! What's more, the faster companies also had quicker approval. Be interesting to see who the slowest were, but the paper (kindly) doesn't show them. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next